DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2026 年 11 月 17 日 1:00 下午 - 2026 年 11 月 19 日 5:00 下午

(Central Europe Standard Time)

4051 Basel, Switzerland

EudraVigilance Data Analysis System (EVDAS): Practical Approach on Use for Signal Management in the EU

This live virtual training course teaches how to effectively access, analyse, and interpret EVDAS data—now a mandatory component of signal management for all MAHs.

Early-Bird rate for DIA Industry Members Available!

DAYS

HOURS

MINUTES

SECONDS

概览

This virtual live training course will teach concepts, access policy, and use of the EudraVigilance Data Analysis System (EVDAS) for signal detection. Experienced trainers using EVDAS on a regular basis will share practical advice on how to download and interpret the data and use it for signal detection.

The EudraVigilance data analysis system (EVDAS) supports EU pharmacovigilance safety monitoring activities with the focus on signal detection and evaluation of ICSRs. Marketing authorisation holders with active substances included in the list published by the European Medicines Agency have to monitor and inform authorities of validated signals with their medicines. GVP Module VII "Periodic Safety Update Reports" states that also for other active substances, MAHs are expected to include data from EudraVigilance whenever there are signal evaluations in the PSUR triggered by other sources of information.

The course is based on the latest guidelines on EU Good Pharmacovigilance Practices (GVP): Module IX – Signal management, Commission Implementing Regulation (EU) No. 520/2012. Time has been set aside for practical exercises, questions, and discussions.

 

Participant Testimonials

The training was very efficient. I gained vast amount of information regarding access policy and valuable practical insight into the EVDAS. I would definitely recommend it to anyone who would like to refresh their knowledge regarding EVDAS or as a source of inspiration to improve their process. – Dr. Barbora Bujdosova – Drug Safety Manager, PRO.MED.CS, Czech Republic

精选主题

    • GVP IX and Addendum I
    • Screening for adverse reactions in EudraVigilance (EV)
    • Principles of access in EV
    • Practical use of EVDAS
    • eRMR analysis and documentation
    • Line listing analysis
    • CMDh list of safety concerns
    • Referrals page on the EMA website
    • List of signals discussed by the PRAC since 2012
    • How to escalate signals, e.g. ESI

谁应该参加?

  • This course is designed for professionals involved in:

    • Pharmacovigilance (including QPPVs)
    • Drug Safety and Patient Safety Risk Management
    • Information Technology
    • Pharmacovigilance Data Management
    • Pharmacovigilance Consultancies
    • Quality and Compliance

     

  • Course level: Intermediate, for professionals with 2-3 years of experience in Pharmacovigilance who work in the area of signal management but have no or limited experience on how to use EVDAS for signal detection.

学习目标

  • At the conclusion of this virtual live training course, participants will be able to:

    • Identify regulatory requirements for Signal Management in Europe (GVP IX and Addendum I)
    • Describe principles of screening EudraVigilance for adverse reactions and the EudraVigilance data access policy
    • Identify levels and methods of access to Individual Case Safety Reports (ICSRs) data and understand the terminology of EVDAS
    • Discuss the use of active substance grouping reports, and electronic reaction monitoring reports (eRMRs)
    • Analyse eRMRs with various reference periods and line listings and document your assessments
    • Identify potential signals and know how to escalate them to the National Competent Authorities (NCAs) and the European Medicines Agency (EMA)

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。